PETV
Closed
Petvivo Holdings Inc
0.78
-0.02 (-2.50%)
Last Update: 01 Jul 2025 22:10:00
Yesterday: 0.7999
Day's Range: 0.77 - 0.7999
Send
sign up or login to leave a comment!
When Written:
2.9
PetVivo Holdings Inc. is a biomedical company that focuses on developing and commercializing innovative medical devices for the veterinary market. The company's products are designed to improve the quality of life of pets and animals by providing effective and affordable treatment options for a range of medical conditions.
PetVivo's flagship product is Kush, a medical device designed to treat osteoarthritis in dogs. Kush is a biocompatible, resorbable, and non-toxic implant that is inserted into the joint space of a dog's knee. It provides support and cushioning to the joint, reducing pain and inflammation and promoting healing.
In addition to Kush, PetVivo is also developing a range of other products for the veterinary market, including a bone graft substitute, a dental implant, and a wound healing device.
PetVivo is headquartered in Minneapolis, Minnesota, and was founded in 2012. The company is publicly traded on the OTCQB market under the ticker symbol PETV.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
PetVivo's flagship product is Kush, a medical device designed to treat osteoarthritis in dogs. Kush is a biocompatible, resorbable, and non-toxic implant that is inserted into the joint space of a dog's knee. It provides support and cushioning to the joint, reducing pain and inflammation and promoting healing.
In addition to Kush, PetVivo is also developing a range of other products for the veterinary market, including a bone graft substitute, a dental implant, and a wound healing device.
PetVivo is headquartered in Minneapolis, Minnesota, and was founded in 2012. The company is publicly traded on the OTCQB market under the ticker symbol PETV.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!